FASEB SRC on Renal Hemodynamics: Integrating with the nephron and beyond
FASEB SRC 肾血流动力学:与肾单位及其他领域的整合
基本信息
- 批准号:8528300
- 负责人:
- 金额:$ 1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcademyAddressAngiotensinsAreaAsiaAustraliaAwardBasic ScienceBiomedical ResearchBlood VesselsClinical InvestigatorCollaborationsCommunicationDataDevelopmentDiabetes MellitusDiseaseDiuresisEnsureEpigenetic ProcessEuropeFeedbackFire - disastersFosteringFrequenciesFunctional disorderFundingHomeostasisHypertensionHypertension induced by pregnancyHypoxiaInflammationInjuryInstitutionKidneyKidney DiseasesKidney FailureMediator of activation proteinMentorsMetabolic syndromeMethodsMinorityNephronsNorth AmericaObesityOralParticipantPathogenesisPathway interactionsPhysiciansPopulationPregnancyReactive Oxygen SpeciesRenal HypertensionRenal functionResearchResearch PersonnelRiversScientistSex CharacteristicsSodiumStructureStudentsSystemTimeTranslatingTranslational ResearchTravelTubular formationUnderrepresented MinorityUnited StatesUpdateVermontWomanWorkblood pressure regulationcareerdesignglomerular functionglomerulosclerosishemodynamicsimprovedinnovationinterestkidney medullakidney vascular structuremeetingsmolecular imagingmultidisciplinarynovelplanetary Atmospherepostersprogramspublic health relevancerenal ischemia/hypoxiaresearch studysymposium
项目摘要
DESCRIPTION (provided by applicant): The 2013 FASEB Summer Research Conference on "Renal Hemodynamics: Integrating with the nephron and beyond" will take place on June 30 through July 5, 2013 at Vermont Academy, Saxtons River, VT. This highly successful, previously well-attended, recurring meeting, held once every three years, will provide a forum for multidisciplinary scientists to meet and openly discuss their most current innovative, translational and basic research on kidney-related diseases in an informal, casual, relaxed atmosphere. We have developed a new, highly interactive format for the meeting to increase the amount of time for discussion and poster sessions which will foster more in-depth interactions especially between established and early career investigators. This includes two "data diuresis" sessions where posters are presented orally in a rapid-fire format prior to the poster session. This has been used at other conferences and successfully stimulates interest in the posters. Also, during the group dinners, senior investigators will be asked to sit with junior investigators
that are not from their own institution. This informal setting allows for greater exchange of ideas
as well as professional development. Conference aims are: 1) to convene an internationally recognized multidisciplinary group of investigators to present and discuss current research findings in the area of renal hemodynamic mechanisms that are the cause or consequence of diseases including hypertension, diabetes, obesity, metabolic syndrome, glomerular sclerosis and nephropathy; 2) to promote the participation of early career investigators; and 3) to promote the participation of women and under-represented minorities. We will initiate participation of early career investigators, women and minorities through targeted recruitment and travel awards. To this end, we have significantly increased participation by these groups as invited speakers and session moderators over previous conferences, at least half of the invited speakers have not presented before or have not presented in at least 12 years. Furthermore, all of the data diuresis sessions will be new investigators. Specific areas to be covered include: renal vascular dysfunction in hypertension and diabetes; novel mechanisms of sodium handling; renal inflammation as a cause of hypertension and renal disease; mechanisms of autoregulation and tubular-vascular communication; sex differences in hypertension and renal function; novel mechanisms of angiotensin system function; epigenetics and pregnancy induced hypertension and renal dysfunction; reactive oxygen species; hypoxia and ischemic injury; and renal medullary hemodynamics.
描述(由申请人提供):2013年FASEB夏季研究会议“肾脏血液动力学:与Nephron及其他人融合”将于2013年6月30日至2013年7月5日在弗吉尼亚州萨克斯顿河佛蒙特州学院举行。这次非常成功的,以前良好的经常会议每三年举行一次,将为多学科科学家提供一个论坛,以在非正式,休闲,轻松的氛围中公开讨论他们有关肾脏相关疾病的最新创新,转化和基础研究。我们为会议开发了一种新的,高度互动的格式,以增加讨论和海报会议的时间,这将促进更深入的互动,尤其是在既定和早期职业调查人员之间。这包括两个“ Data Diuresis”会话,其中海报在海报会话之前以快速形式的格式提供了海报。这已在其他会议上使用,并成功刺激了对海报的兴趣。此外,在小组晚餐期间,将要求高级调查员与初级调查人员坐在一起
不是来自他们自己的机构。这种非正式的环境允许更多的想法交流
以及专业发展。 会议的目的是:1)召集国际认可的多学科研究人员组,以介绍和讨论肾脏血流动力学机制领域的最新研究结果,这些研究结果是疾病的原因或后果,包括高血压,糖尿病,肥胖,肥胖,代谢综合征,肾小球硬膜病和肾上腺炎; 2)促进早期职业调查人员的参与; 3)促进妇女和代表性不足的少数民族的参与。我们将通过有针对性的招募和旅行奖开始早期职业调查员,妇女和少数民族的参与。为此,作为邀请的演讲者和会议主持人,这些群体的参与度大大增加了以前的会议,至少有一半的被邀请的演讲者以前没有提出或至少在12年中没有介绍。此外,所有数据Diuresis会议都将是新的研究人员。 要涵盖的特定区域包括:高血压和糖尿病的肾血管功能障碍;钠处理的新型机制;肾脏炎症是高血压和肾脏疾病的原因;自动调节和管状血管通信的机制;高血压和肾功能的性别差异;血管紧张素系统功能的新型机制;表观遗传学和妊娠诱导的高血压和肾功能障碍;活性氧;缺氧和缺血性损伤;和肾脏髓质血流动力学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID M POLLOCK其他文献
DAVID M POLLOCK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID M POLLOCK', 18)}}的其他基金
Deep South KUH Premier Research - Interdisciplinary Mentored Education (PRIME) Training Core
深南 KUH Premier Research - 跨学科指导教育 (PRIME) 培训核心
- 批准号:
10889499 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Timing of Diet and Kidney Pathophysiology in Diet-Induced Obesity
饮食引起的肥胖的饮食时机和肾脏病理生理学
- 批准号:
10735631 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Integrating novel mechanisms controlling sodium excretion and blood pressure
整合控制钠排泄和血压的新机制
- 批准号:
9922350 - 财政年份:2017
- 资助金额:
$ 1万 - 项目类别:
Integrating novel mechanisms controlling sodium excretion and blood pressure
整合控制钠排泄和血压的新机制
- 批准号:
10267370 - 财政年份:2017
- 资助金额:
$ 1万 - 项目类别:
ENDOTHELIN CONTROL OF RENAL HEMODYNAMIC AND EXCRETORY FUNCTION
内皮素对肾脏血流动力学和排泄功能的控制
- 批准号:
8464198 - 财政年份:2010
- 资助金额:
$ 1万 - 项目类别:
ENDOTHELIN CONTROL OF RENAL HEMODYNAMIC AND EXCRETORY FUNCTION
内皮素对肾脏血流动力学和排泄功能的控制
- 批准号:
8125044 - 财政年份:2010
- 资助金额:
$ 1万 - 项目类别:
ENDOTHELIN CONTROL OF RENAL HEMODYNAMIC AND EXCRETORY FUNCTION
内皮素对肾脏血流动力学和排泄功能的控制
- 批准号:
8661220 - 财政年份:2010
- 资助金额:
$ 1万 - 项目类别:
ENDOTHELIN CONTROL OF RENAL HEMODYNAMIC AND EXCRETORY FUNCTION
内皮素对肾脏血流动力学和排泄功能的控制
- 批准号:
8266432 - 财政年份:2010
- 资助金额:
$ 1万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
- 批准号:
10642368 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Activity and therapeutic antagonism of the TP receptor in cardiomyopathy of muscular dystrophy
TP受体在肌营养不良性心肌病中的活性和治疗拮抗作用
- 批准号:
10736005 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
ANG1-7 as an intervention for Alzheimer's Disease.
ANG1-7 作为阿尔茨海默病的干预措施。
- 批准号:
10592577 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Sodium Dodecyl Sulfate Removal Interface to Enable Characterization of Fragment Impurities in Monoclonal Antibodies by Capillary Electrophoresis Sodium Dodecyl Sulfate Coupled to Mass Spectrometry
十二烷基硫酸钠去除接口可通过十二烷基硫酸钠毛细管电泳与质谱联用对单克隆抗体中的片段杂质进行表征
- 批准号:
10759354 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别:
Addressing the Racial Disparity of Angiotensin Inhibitor Benefit in HFrEF Hospitalizations: Distinguishing Genomic and Social Factors
解决 HFrEF 住院期间血管紧张素抑制剂获益的种族差异:区分基因组和社会因素
- 批准号:
10605868 - 财政年份:2023
- 资助金额:
$ 1万 - 项目类别: